Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Neurology researchers explore link between MS and chronic cerebrospinal venous insufficiency

More than 55 percent of multiple sclerosis patients participating in the initial phase of the first randomized clinical study to determine if persons with MS exhibit narrowing of the extracranial veins, causing restriction of normal outflow of blood from the brain, were found to have the abnormality.

11 Feb 2010

fMRI study shows neural network may be brain's back burner for social decision making

When we put an idea on the back burner, it goes into a processing area of the brain called the default-mode network. This network enables us to hold the low-priority idea in abeyance until a time when we aren't busy with something else.

11 Feb 2010

Mental health 'bible' starts revamp with new terminology, diagnoses

The Wall Street Journal: "Mental-health experts wrestling with how to fit temper tantrums, hoarding and even Internet addiction into the current understanding of mental illness are proposing changes to the field's primary reference for diagnoses for the first time in 16 years. The draft revisions of the Diagnostic and Statistical Manual of Mental Disorders—the bible for mental health clinicians and researchers—unveiled Wednesday could have effects that ripple through mental health care."

11 Feb 2010

Study: There are still barriers to veterans getting full course of PTSD treatment

Although the Department of Veteran Affairs is rolling out treatments nationwide as fast as possible to adequately provide for newly diagnosed PTSD patients, there are still significant barriers to veterans getting a full course of PTSD treatment. The study is published in the latest issue of the Journal of Traumatic Stress.

11 Feb 2010

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel glycine site functional partial agonist (GFPA) NMDA receptor modulators, today reported positive top-line results from its Phase I clinical trial of lead compound GLYX-13.

10 Feb 2010

Autism Speaks: Ten most significant autism research achievements in 2009

Autism Speaks, the world's largest autism science and advocacy organization has released its annual list of the 10 most significant research achievements to have impacted autism during the previous year. Every year, Autism Speaks documents the progress made toward its mission to discover the causes and treatment for autism spectrum disorders, and compiles a list of the 10 most significant research achievements to have impacted autism during the previous year.

10 Feb 2010

Study challenges clinical myths about effects of depression on cognitive functioning

Many clinicians believe that depression goes hand in hand with cognitive difficulties such as memory problems or difficulties concentrating and paying attention, but a recent review of nearly 20 years of literature conducted by researchers from UT Southwestern Medical Center has found that depression does not always lead to such impairments.

10 Feb 2010

Marijuana ineffective against Alzheimer's disease in animal model

The benefits of marijuana in tempering or reversing the effects of Alzheimer's disease have been challenged in a new study by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.

8 Feb 2010

Investigational drug for osteoporosis inhibits serotonin synthesis in the gut

An investigational drug that inhibits serotonin synthesis in the gut, administered orally once daily, effectively cured osteoporosis in mice and rats reports an international team led by researchers from Columbia University Medical Center, in the Feb. 7 issue of Nature Medicine.

7 Feb 2010

Link between anti-gay sentiment and suicidality: Further study needed

Mental health professionals have long-known that gay, lesbian and bisexual (GLB) teens face significantly elevated risks of mental health problems, including suicidal thoughts and suicidal attempts. However, a group of McGill University researchers in Montreal has now come to the conclusion that self-identity is the crucial risk-factor, rather than actual sexual behaviours. Their results were published in February in the Journal of the American Academy of Child & Adolescent Psychiatry.

6 Feb 2010

Teens with suicidal thoughts and depressive symptoms can benefit from family therapy

Adolescents with suicidal thoughts and elevated depression had stronger and faster reduction of symptoms when treated with family therapy than with standard treatment in the community.

5 Feb 2010

Study finds high levels of depression among children abused in the first five years of their lives

Although children can be depressed for many reasons, new evidence suggests that there are physiological differences among depressed children based on their experiences of abuse before age 5. Early abuse may be especially damaging due to the very young age at which it occurs.

5 Feb 2010

LDDI releases biomonitoring report on environmental neurotoxins in health affected community

The Learning and Developmental Disabilities Initiative (LDDI) today released the first-ever biomonitoring report identifying toxic chemical pollution in people from the learning and developmental disability community.

5 Feb 2010

Scientists still searching for valid biomarker for schizophrenia and bipolar disorder

Schizophrenia and bipolar disorder affect tens of millions of individuals around the world. These disorders have a typical onset in the early twenties and in most cases have a chronic or recurring course.

4 Feb 2010

Neuroscience research and clinical care launched at UT Medical School

Innovative neuroscience research and expanded clinical care have been launched at the new Center of Excellence on Mood Disorders at The University of Texas Medical School at Houston.

4 Feb 2010

Anomalies causing motivational deficiencies may also cause ADHD

Until now, attention-deficit/hyperactivity disorder (ADHD) was related to alterations in the brain affecting attention and cognitive processes. Researchers at Universitat Autònoma de Barcelona and the Vall d'Hebron University Hospital for the first time have discovered anomalies in the brain's reward system related to the neural circuits of motivation and gratification. In children with ADHD, the degree of motivation when carrying out an activity is related to the immediacy with which the objectives of the activity are met. This would explain why their attention and hyperactivity levels differ depending on the tasks being carried out.

4 Feb 2010

UCSF studies show relationship between Alzheimer's disease and smoking

A UCSF analysis of published studies on the relationship between Alzheimer's disease and smoking indicates that smoking cigarettes is a significant risk factor for the disease. After controlling for study design, quality of the journals, time of publication, and tobacco industry affiliation of the authors, the UCSF research team also found an association between tobacco industry affiliation and the conclusions of individual studies.

4 Feb 2010

Researchers discover anomalies that cause lack of motivation in ADHD children

3 Feb 2010

FDA approves Labopharm's OLEPTRO antidepressant for MDD

Labopharm Inc. today announced the U.S. Food and Drug Administration (FDA) has approved OLEPTRO(TM) (trazodone hydrochloride) Extended Release Tablets, a novel once-daily formulation of the antidepressant trazodone, for the treatment of major depressive disorder (MDD) in adults. OLEPTRO(TM) utilizes CONTRAMID(R), Labopharm's clinically validated technology that controls the release of active substances within oral medications.

3 Feb 2010

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Experts from the University of Pennsylvania School of Medicine are available to offer expert medical insight and commentary during the 2010 Winter Olympics in Vancouver on issues ranging from the effects of performance enhancing drugs to concerns about the spread of novel H1N1, head trauma and more.

3 Feb 2010

Psychiatry News and Research

Further Reading

Neurology researchers explore link between MS and chronic cerebrospinal venous insufficiency

fMRI study shows neural network may be brain's back burner for social decision making

Mental health 'bible' starts revamp with new terminology, diagnoses

Study: There are still barriers to veterans getting full course of PTSD treatment

Positive results from Naurex's Phase I clinical trial of GLYX-13 reported

Autism Speaks: Ten most significant autism research achievements in 2009

Study challenges clinical myths about effects of depression on cognitive functioning

Marijuana ineffective against Alzheimer's disease in animal model

Investigational drug for osteoporosis inhibits serotonin synthesis in the gut

Link between anti-gay sentiment and suicidality: Further study needed

Teens with suicidal thoughts and depressive symptoms can benefit from family therapy

Study finds high levels of depression among children abused in the first five years of their lives

LDDI releases biomonitoring report on environmental neurotoxins in health affected community

Scientists still searching for valid biomarker for schizophrenia and bipolar disorder

Neuroscience research and clinical care launched at UT Medical School

Anomalies causing motivational deficiencies may also cause ADHD

UCSF studies show relationship between Alzheimer's disease and smoking

Researchers discover anomalies that cause lack of motivation in ADHD children

FDA approves Labopharm's OLEPTRO antidepressant for MDD

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News